We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Company Seeks To Enjoin FDA From Restricting Speech About Off-Label Uses

(September 30, 2015, 10:49 AM EDT) -- NEW YORK — On the heels of a ruling in a similar case, Pacira Pharmaceuticals Inc. on Sept. 8 filed a declaratory action seeking to enjoin the Food and Drug Administration from prohibiting the company from making truthful and nonmisleading speech about off-label uses for one of its products (Pacira Pharmaceuticals, Inc., et al. v. United States Food & Drug Administration, et al., No. 15-7055, S.D. N.Y.).

(Pacira complaint available. Document #28-151001-016C.)

Pacira makes and markets Exparel, a combination of the local anesthetic bupivacaine and DepoFoam....
To view the full article, register now.